DTRK.US DATATRAK International Inc

Healthcare Health Care Technology USA Stocks
0.2900 USD
Close of Nov 14, 2026
0.1700 0.8800
Market cap
USD 8.03M
P/E
-
P/B
-
ROE
42.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is DTRK.US undervalued?

Graham number

The Graham number of DATATRAK International Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DATATRAK International Inc fundamental analysis

No fundamental analysis for DATATRAK International Inc yet.

DATATRAK International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DATATRAK International Inc

DATATRAK International, Inc., a technology and services company, provides unified clinical solutions and related services for the clinical trials industry. The company offers DATATRAK ONE Unified Experience, a clinical enterprise solution that allows clinical users and service providers to design, deliver, and manage clinical trials. Its products include UX CTMS 360 for planning and managing trials; UX Trial to streamline design-to-deployment process using a tool; UX EDC & M…

Full company profile